Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-05-23

Clinical Trial Update: Effect of Lidocaine Transdermal Patch as Add-On Therapy in Treatment of Oxaliplatin Induced Peripheral Neuropathy in Colorectal Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a lidocaine transdermal patch as add-on therapy for oxaliplatin-induced peripheral neuropathy in colorectal cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • lidocaine transdermal patch (lidocaine transdermal patch)

Snippet

Sponsor: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | Conditions: Oxaliplatin Induced Peripheral Neuropathy in Cancer Patients | Phase 2 | Status: UNKNOWN